 This is a phase 1 study, in healthy volunteers who have previously been immunized with bacilli Calmette Guerin BCG, to evaluate the safety and immune responses that develop in the blood and lungs following the administration by aerosol of a new experimental adenovirus-based vaccine for tuberculosis TB, Ad5Ag85A. 